TD Cowen Cuts Teladoc Health (NYSE:TDOC) Price Target to $8.00

Teladoc Health (NYSE:TDOC) had its price objective trimmed by TD Cowen from $9.00 to $8.00 in a research report report published on Thursday, Benzinga reports. They currently have a hold rating on the health services provider’s stock.

Several other equities analysts also recently issued reports on the stock. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a report on Thursday, August 1st. Truist Financial cut their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research note on Friday, August 2nd. DA Davidson reduced their target price on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a report on Thursday, August 1st. Oppenheimer dropped their price target on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a report on Thursday, August 1st. Finally, Evercore ISI boosted their price objective on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Fourteen research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Teladoc Health presently has an average rating of “Hold” and a consensus target price of $11.97.

Teladoc Health Stock Up 2.3 %

NYSE TDOC opened at $9.21 on Thursday. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $22.54. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of -1.60 and a beta of 0.90. The stock’s 50 day moving average is $8.48 and its two-hundred day moving average is $9.69. The company has a current ratio of 1.66, a quick ratio of 1.62 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. The firm had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative return on equity of 9.40% and a negative net margin of 37.91%. Equities analysts forecast that Teladoc Health will post -1.18 earnings per share for the current fiscal year.

Insider Transactions at Teladoc Health

In related news, CFO Mala Murthy sold 8,750 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $62,650.00. Following the transaction, the chief financial officer now directly owns 85,767 shares in the company, valued at $614,091.72. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other Teladoc Health news, CFO Mala Murthy sold 8,750 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the sale, the chief financial officer now owns 85,767 shares in the company, valued at approximately $614,091.72. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CMO Stephany Verstraete sold 15,000 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $7.60, for a total value of $114,000.00. Following the completion of the transaction, the chief marketing officer now owns 45,158 shares in the company, valued at $343,200.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 36,588 shares of company stock worth $268,831 in the last quarter. 0.95% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

A number of institutional investors and hedge funds have recently modified their holdings of TDOC. Robeco Institutional Asset Management B.V. boosted its stake in Teladoc Health by 141.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 575,055 shares of the health services provider’s stock worth $5,279,000 after acquiring an additional 337,305 shares during the last quarter. Janney Montgomery Scott LLC boosted its position in shares of Teladoc Health by 63.0% during the third quarter. Janney Montgomery Scott LLC now owns 106,727 shares of the health services provider’s stock worth $980,000 after purchasing an additional 41,250 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Teladoc Health in the 3rd quarter valued at $111,000. Assenagon Asset Management S.A. bought a new stake in shares of Teladoc Health in the 3rd quarter valued at $15,801,000. Finally, International Assets Investment Management LLC increased its position in shares of Teladoc Health by 693.0% in the 3rd quarter. International Assets Investment Management LLC now owns 23,299 shares of the health services provider’s stock valued at $214,000 after buying an additional 20,361 shares in the last quarter. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.